Virtual Advocate Leadership Summit Program

Plenary Sessions

  • Breast Cancer Disparities: Taking steps toward impactful solutions
  • Artemis Update
  • “Warp Speed” Science: When does it happen and why? 
  • The Biden Administration and Women’s Health 

Workshops

  • Breast Cancer Models 2.0
  • Immune Checkpoint Inhibitors: Biological mechanisms, PDL1 expression assays, and their role in breast cancer
  • Breast Cancer and Microbiome
  • mRNA Vaccines: What are they, how are they different from traditional vaccines, and is there a role for these types of vaccines in breast cancer?
  • How to Engage Members of Congress at Home (and Why it is a Good Idea)
  • How to Get Your Legislator’s Attention
  • Can’t We All Just Get Along? How to Get Things Done in a Narrowly Divided Congress

Armchair Interview 

  • Interview with Dr. Susan Love
    NBCC President Fran Visco has a conversation with Dr. Susan Love on NBCC, the history of breast cancer advocacy, and how things have changed over time.

Project LEAD Workshop Topics 

  • CDK 4/6 Inhibitors in Breast Cancer (Advanced and Adjuvant Settings)

Confirmed Speakers 

  • Lucile L Adams-Campbell, PhD, Lombardi Comprehensive Cancer Center at Georgetown University Medical Center
  • Otis Brawley, MD, Sidney Kimmel Comprehensive Cancer Center, School of Medicine, Department of Epidemiology, Bloomberg School of Public Health
  • Robert Cook-Deegan, MD, Arizona State University
  • Daniel Douek, MD, PhD, Chief, Vaccine Research Center, NIAID, NIH, DHHS
  • Ivis Febus-Sampayo, NBCC Board of Directors; Chief Diversity Officer, SHARE
  • Cyrus Ghajar, PhD, Fred Hutchinson Cancer Research Center
  • Pat Haugen, MS, NBCC Board of Directors Alternate, Minnesota Breast Cancer Coalition
  • Matt Hepburn, MD, Joint Product Lead at US Army
  • Judi Hirshfield-Bartek, RN, MS, OCN, NBCC Board of Directors, Dr. Susan Love Research Foundation
  • Sara Hurvitz, MD, University of California Los Angeles, Jonsson Comprehensive Cancer Center
  • Keith Knutson, PhD, Mayo Clinic
  • Susan Love, MD, Dr. Susan Love Foundation
  • Wanda Lucas, MBA, CPCC, NBCC Board of Directors, Metropolitan Washington, DC Chapter of NBCC
  • Roslyn Holliday Moore, MS Deputy Director for Programs, HHS Office of Minority Health
  • Mark Pulido, MPP, Deputy Chief of Staff, Office of Congressman Alan Lowenthal
  • Neera Tanden, JD, President and CEO, Center for American Progress
  • Sara Tolaney, MD, MPH, Dana-Farber/Harvard Cancer Center
  • Fran Visco, JD, National Breast Cancer Coalition
  • Nathaniel Wang, PhD, Chief Executive Officer and Chief Scientific Officer at Replicate
  • Alana Welm, PhD, University of Utah

To return to the main summit page, click here.